Literature DB >> 16260800

Venous thromboprophylaxis in UK medical inpatients.

S T Rashid1, M R Thursz, N A Razvi, R Voller, T Orchard, S T Rashid1, A A Shlebak.   

Abstract

We prospectively assessed the implementation of venous thromboembolism (VTE) prophylaxis guidelines and the impact of grand round presentation of the data in changing clinical practice. Two NHS teaching hospitals were studied for 24 months from January 2003. Patients were risk stratified according to the THRIFT (thromboembolic risk factor) consensus group guidelines and compared with the recommendations of the THRIFT and ACCP (American College of Chest Physicians) consensus groups. Six months following presentation of the initial results, a further analysis was made to assess changes in clinical practice. 1128 patients were assessed of whom 1062 satisfied the inclusion criteria for thromboprophylaxis. 89% of all patients were stratified as having high or moderate risk of developing VTE. Of these only 28% were prescribed some form of thromboprophylaxis-4% received the THRIFT-recommended and 22% received the ACCP-recommended thromboprophylaxis. The vast majority (72%) received no thromboprophylaxis at all. Reassessment, following data presentation at grand rounds, showed a significant increase to 31% inpatients receiving THRIFT (P<0.0001) and ACCP (P=0.002) recommended thromboprophylaxis. However,the proportion of patients receiving no form of prophylaxis barely changed (72% to 69%: P=0.59). We found a gross underutilization of thromboprophylaxis in hospitalized medical patients. A simple grand-round presentation of the data and recommended guidelines to clinicians significantly increased the proportion of patients receiving recommended thromboprophylaxis but did not increase the overall proportion of patients receiving it. We therefore conclude that a single presentation of guidelines is not enough to achieve the desired levels. Such presentations may only serve to make DVT (deep venous thromboembolism) aware clinicians prescribe prophylaxis more accurately.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260800      PMCID: PMC1275999          DOI: 10.1177/014107680509801112

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  24 in total

1.  A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.

Authors:  G Simonneau; H Sors; B Charbonnier; Y Page; J P Laaban; R Azarian; M Laurent; J L Hirsch; E Ferrari; J L Bosson; D Mottier; B Beau
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

2.  A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

Authors:  F A Anderson; H B Wheeler; R J Goldberg; D W Hosmer; N A Patwardhan; B Jovanovic; A Forcier; J E Dalen
Journal:  Arch Intern Med       Date:  1991-05

Review 3.  Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

Authors: 
Journal:  BMJ       Date:  1992-09-05

Review 4.  The natural history and epidemiology of venous thrombosis.

Authors:  C J Carter
Journal:  Prog Cardiovasc Dis       Date:  1994 May-Jun       Impact factor: 8.194

5.  The clinical course of pulmonary embolism.

Authors:  J L Carson; M A Kelley; A Duff; J G Weg; W J Fulkerson; H I Palevsky; J S Schwartz; B T Thompson; J Popovich; T E Hobbins
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

6.  Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.

Authors:  H R Büller; M Gent; A S Gallus; J Ginsberg; M H Prins; R Baildon
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

7.  Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis.

Authors:  D P Brandjes; H R Büller; H Heijboer; M V Huisman; M de Rijk; H Jagt; J W ten Cate
Journal:  Lancet       Date:  1997-03-15       Impact factor: 79.321

Review 8.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  William H Geerts; Graham F Pineo; John A Heit; David Bergqvist; Michael R Lassen; Clifford W Colwell; Joel G Ray
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

9.  Physicians' practice for prevention of venous thromboembolism in medical patients.

Authors:  Abdullah A Abba; Mohammed A Al Ghonaim; Ahmed M Rufai
Journal:  J Coll Physicians Surg Pak       Date:  2004-04       Impact factor: 0.711

10.  A prospective study of the incidence of deep-vein thrombosis within a defined urban population.

Authors:  M Nordström; B Lindblad; D Bergqvist; T Kjellström
Journal:  J Intern Med       Date:  1992-08       Impact factor: 8.989

View more
  23 in total

Review 1.  Medical ultrasound: imaging of soft tissue strain and elasticity.

Authors:  Peter N T Wells; Hai-Dong Liang
Journal:  J R Soc Interface       Date:  2011-06-16       Impact factor: 4.118

2.  Rectus sheath haematoma: a serious complication of a commonly administered drug.

Authors:  Fran Parkinson; Usman Khalid; Justin Woolgar
Journal:  BMJ Case Rep       Date:  2013-04-10

3.  British and Eire Association of Vitreoretinal Surgeons (BEAVRS)-based survey on venous thromboembolism (VTE) prophylaxis in vitreoretinal (VR) surgery.

Authors:  S Waqar; E Doyle
Journal:  Eye (Lond)       Date:  2010-12-03       Impact factor: 3.775

4.  Improving venous thromboembolic disease prophylaxis in medical inpatients: a role for education and audit.

Authors:  B D Kent; P Nadarajan; N B Akasheh; I Sulaiman; S Karim; S Cooney; S J Lane; E D Moloney
Journal:  Ir J Med Sci       Date:  2010-10-19       Impact factor: 1.568

Review 5.  Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process.

Authors:  Franklin A Michota
Journal:  J Gen Intern Med       Date:  2007-09-22       Impact factor: 5.128

6.  Pattern of Venous Thrombosis in Cancer Patients: Frequency and Survival Effect; Single Center Experience.

Authors:  Amrallah A Mohammed; Abdullah S Al-Zahrani; Mian U Farooq; Hafez M Ghanem; Lobna A Abdelaziz; Hani M El-Khatib
Journal:  Indian J Hematol Blood Transfus       Date:  2015-01-23       Impact factor: 0.900

7.  Underutilization of venous thromboemoblism prophylaxis in medical patients in a tertiary care center.

Authors:  Ramy Masroujeh; Wael Shamseddeen; Hussain Isma'eel; Zaher K Otrock; Ismail M Khalil; Ali Taher
Journal:  J Thromb Thrombolysis       Date:  2007-08-15       Impact factor: 2.300

Review 8.  Venous thromboembolism in ENT surgery: a review of the literature and completed audit cycle of adherence to national guidance.

Authors:  Raj Lakhani; Vishal Narwani; Adam Bromby; Andreas W Hilger
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-30       Impact factor: 2.503

Review 9.  Current issues in thromboprophylaxis in the elderly.

Authors:  Parminder S Chaggar; Kevin S Channer
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Challenges in implementing government-directed VTE guidance for medical patients: a mixed methods study.

Authors:  Avril Janette Basey; Janet Krska; Tom D Kennedy; Adam John Mackridge
Journal:  BMJ Open       Date:  2012-11-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.